B

Baroness Merron (Lab)

Speaking in the House of Lords on 12 October 2026

Debate

Weight-loss Drugs

Contribution

Both the questions my noble friend asks are very important. The Government recently conducted a call for evidence looking at the safety of private and online prescribing environments, and we are in the process of carefully considering the responses. I can also say to my noble friend that NICE guidance supports the prioritisation of NHS resources. It is certainly the current practice for NICE to review recommendations where there is significant new evidence, as it will be doing in late 2027 in respect of Mounjaro.

More from Baroness Merron (Lab)

Other recent Hansard contributions by the same speaker.

About Hansard

Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.